维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Pockros P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	GI-5005 therapeuticvaccine plus peg-IFN/ribavirin improves sustained virologicresponse virus peg-IFN/ribavirin in prior non-responders withgenotype 1 chronic HCY infection 显示文摘	Pockros P Jacobson I Boyer TD	2010	Hepatology2010，52，：	1
2	Impact of obesity on treatment of chronic hepatitis C显示文摘	CHARLTON MR POCKROS P J HARRISON SA	2006	Hepatology2006，43，6：	1
3	Developments in treatment of chronic hepatitis C显示文摘	Pockros P J	2002	Exp Opin Invest Drugs2002，11，4：	1
4	Peginterferon- a2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose 显示文摘	Hadziyannis SJ Sette H Jr Morgan TR Balan V Diago M Marcellin P Ramadori G Bodenheimer H Jr Bernstein D Rizzetto M Zeuzem S Pockros PJ Lin A Ackrill AM PEGASYS International Study Group	2004	Ann Intern Med2004，140，5：	1
5	Efficacy of pegylated(40 kDa) interferon alfa-2a(PEGASYS) in randomized trials of patients with chronic hepatitis C, with and without cirrhosis: correlation of virological responses with baseline liver histology and genotype显示文摘	Pockros P J Heathcote E J Shiffman ML	2000	Hepatology2000，32，42：	1
6	Telaprevir for retreatment of HCV infection 显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team	2011	N Engl J Med2011，364，25：	1
7	HCV RNA viral load assessments in the era of direct-acting antivirals 显示文摘	Cobb B Pockros P J Vilchez R A	2013	Am JGastroenterol2013，108，4：	1
8	A phase Ⅰ trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients 显示文摘	McHutchison J G Patel K Pockros P	2006	J Hepatol2006，44，1：	1
9	Efficacy and safety of pe- gylated (40-kd) interferon alpha-2a compared with interferon alpha- 2a in noncirrhotic patients with chronic hepatitis C 显示文摘	Reddy KR Wright TL Pockros P J	2001	Hepatology2001，33，2：	1
10	Telaprevir for retreatment of HCV infection显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Focaccia R Younossi Z Foster G R Horban A Ferenci P Nevens F Müllhaupt B Pockros P Terg R Shouval D Hoek B Weiland O Heeswijk R Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M	2011	N Engl J Med2011，364，25：	1
11	Aphase 1 trial ofall antisense inhibitor of hepatitis C virus ( ISIS 14803), adminis tered to chronic hepatitis C patients显示文摘	McHutchison JG Patel K Pockros P	2006	J Hepatol2006，44，：	1
12	First SVR data with the nucleoside analogue polymerase inhibitor mericitabine(RG7128)combined with peginterferon/ribavirin in treatmentnaive HCV G1/4patients:interim analysis from the JUMP-C trial显示文摘	Pockros P Jensen D Tsai N	2011	Journal of Hepatology2011，，1：	1
13	A controlled,randomized multi-center, descending dose phase Ⅱ trial of pegvlated interferon α-2a(PEG) vs standard interferon α -2a (IFN)for treatment of chronic hepatitis C显示文摘	Schiffman M Pockros P J Reddy R K	1999	Gastroenterology1999，116，2：	1
14	Idiopathic fatty liver of pregnancy:Findings in ten cases显示文摘	POCKROS P PETERS R REYNOLDS T	1984	Medicine (Baltimore)1984，63，：	1
15	Drugs in development for chronic hepatitis C: a promising future 显示文摘	POCKROS P J	2011	Expert Opin Biol Ther2011，11，12：	1
16	A phase 2, randomized study of HCV -76 in combination with pegylated -interferon (PEG) plus ribavirin (RBV) versus PEG plus RBV in hepatitis C virus genotype - 1 infection显示文摘	POCKROS P RODRIGUE Z -TORRES M VlLLANO S	2009	J Hep- atol2009，50，1：	1
17	R1626 plus peginterferon alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin显示文摘	Pockros P J Nelson D Godofsky E	2008	Hepatology2008，48，2：	1
18	Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis显示文摘	Goodman ZD Becker RL Jr Pockros P J	2007	Hepatology2007，45，：	1
19	Idiopathic fatty liver of preg- nancy: findings in ten cases 显示文摘	Pockros P J Peters RL Reynolds TB	1984	Medicine1984，63，1：	1
20	A phase I trial of an antisense inhibitor of hepatitis C virus ( ISIS 14803), administered to chronic hepatitis C patients 显示文摘	McHUTCHISON JG PATEL K POCKROS P	2006	J Hepatol2006，44，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示